Last reviewed · How we verify

NCT06077942

FX Shoulder Solutions Retrospective / Prospective Clinical Study

Recruiting now Last updated 12 October 2023
What this trial tests

trial testing FX Artificial Shoulder Prosthesis in Rotator Cuff Syndrome of Shoulder and Allied Disorders in 600 participants. Currently enrolling.

Timeline
6 December 2022
Primary endpoint
30 December 2032
30 December 2032

Quick facts

Lead sponsorFX Shoulder Solutions
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment600
Start date6 December 2022
Primary completion30 December 2032
Estimated completion30 December 2032
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

FX Shoulder Solutions

Who can join

Eligibility, any sex, with Rotator Cuff Syndrome of Shoulder and Allied Disorders or Osteoarthritis Shoulder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Subjects implanted with the shoulder replacement medical devices manufactured by FX Shoulder Solutions and distributed by FX Shoulder Solutions.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of FX Artificial Shoulder Prosthesis

Trials testing the same drug.

Other recruiting trials for Rotator Cuff Syndrome of Shoulder and Allied Disorders

Currently open trials in the same condition.

Other FX Shoulder Solutions trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06077942.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing